Data / Form D filings / Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc.: Form D filing
Lifeline Biotechnologies, Inc., a biotechnology company in Reno, NV, filed a Form D with the SEC in 2009. The latest, on November 4, 2009, reports $200,000 sold of a $750,000 offering to 1 investor.
Find out what Lifeline Biotechnologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1325 AIRMOTIVE WAY, SUITE 175, Reno, NV, 89592
- Phone
- (775) 852-3222
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 504(b)(1)(iii)
- SEC identifier (CIK)
- 932276
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2009 | New notice | $750,000 | $200,000 | $550,000 | 1 | Oct 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Louis Keith | Director | |
| Jim Holmes | Director, Executive Officer |
Other biotechnology companies in Nevada that filed recently
- Conexeu Sciences Inc. $4,801 · Nov 5, 2026
- Palimpsest Bio Corp. $172,000 · Oct 30, 2026
Every Form D from the week of Nov 2, 2009 · All recent filings in Nevada · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lifeline Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.